Lymphoepithelioma-like carcinoma of the bladder: a case report

Lymphoepithelioma-like carcinoma (LELCB), Lymphoepithelioma-like carcinoma of the bladder (LELCB) is a rare subtype of urothelial carcinoma, accounting for less than 1.3% of all pathological types of malignant bladder tumors. Due to the rarity of the cases, surgical resection and postoperative adjuvant therapy are currently the main treatment methods, and standardized treatment protocols and prognostic factors are not yet fully clarified. This article reported a case of an 86-year-old woman who visited the hospital due to painless gross hematuria. Urinary system color Doppler ultrasound and computed tomography (CT) of the bladder both suggested a tumor on the right anterior wall of the bladder. After transurethral resection of bladder tumor, the postoperative pathology confirmed LELCB. The patient relapsed after 11 months of regular chemotherapy. Due to aging and the occurrence of complications such as hypertension, diabetes, and COPD, the patient still chose to undergo partial cystectomy after recurrence. Postoperative pathology still indicated lymphoepithelioma-like carcinoma of the bladder. Unfortunately, the patient did not undergo further adjuvant therapy.